EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS

Dana Strouhalova iD, Dana Macejova iD, Julius Brtko iD, Janette Bobalova iD

Journal of Mass Spectrometry · 2026

DOI: 10.1002/jms.70090 ↗

At a glance

Journal article in Journal of Mass Spectrometry, 2026. Written by Dana Strouhalova and 3 co-authors. Institution: Institute of Analytical Chemistry of the CAS, Brno, Czech Republic. Major MEDLINE topics: Trialkyltin Compounds, Heat-Shock Proteins, Propionates, Retinoid X Receptors. 30 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: institutional support, Agentúra na Podporu Výskumu a Vývoja, Vedecká Grantová Agentúra MŠVVaM SR a SAV.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Organotin (IV) compounds are known to induce apoptosis via the intrinsic mitochondrial pathway, which is a key mechanism of effective anticancer therapy. Their ability to selectively promote apoptotic cell death highlights their potential as chemotherapeutic agents. In this study, the in vitro effects of two triorganotin compounds, tributyltin propionate and tributyltin salicylate, on the human breast cancer cell line MDA‐MB‐231 were evaluated. In addition to their proven antitumor activity, these compounds may act as synthetic ligands for nuclear retinoid X receptors. Protein expression profiles were examined using gel electrophoresis and MALDI‐TOF mass spectrometry, with a particular focus on heat shock proteins (HSPs), which are commonly overexpressed in cancer cells and contribute to tumor progression and therapeutic resistance. Both triorganotin derivatives significantly reduced HSP expression, suggesting that HSPs could be a promising target in cancer therapy.

Subjects

MeSH terms (MEDLINE)

Trialkyltin CompoundsHeat-Shock ProteinsPropionatesRetinoid X ReceptorsAntineoplastic AgentsSalicylatesHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTandem Mass SpectrometryBreast NeoplasmsMDA-MB-231 CellsFemaleLigands

Author keywords

MALDI MS/MSbreast cancerheat shock proteins familyproteomictributyltin salicylate and tributyltin propionate

Substances

Trialkyltin CompoundstributyltinHeat-Shock ProteinsPropionatesRetinoid X ReceptorsLigandsAntineoplastic AgentsSalicylates

Authors and institutions

  • Institute of Analytical Chemistry of the CAS, Brno, Czech Republic.
  • Institute of Experimental Endocrinology, Biomedical Research Center of the SlovakAcademy of Sciences, Bratislava, Slovak Republic.

ORCID profiles: Dana Strouhalova, Dana Macejova, Julius Brtko, Janette Bobalova

Funding

  • institutional support
  • Agentúra na Podporu Výskumu a Vývoja
  • Vedecká Grantová Agentúra MŠVVaM SR a SAV
  • Vedecká Grantová Agentúra MŠVVaŠ SR a SAV

Cite

APA

Strouhalova, D., Macejova, D., Brtko, J., & Bobalova, J. (2026). Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.70090

Vancouver

Strouhalova D, Macejova D, Brtko J, Bobalova J. Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS. Journal of Mass Spectrometry. 2026. doi:10.1002/jms.70090

BibTeX
@article{Strouhalova2026,
  author = {Strouhalova, Dana and Macejova, Dana and Brtko, Julius and Bobalova, Janette},
  title = {Monitoring the Effect of Tributyltin Salicylate and Propionate, Retinoid X Receptor Ligands, on Heat Shock Protein Expression in MDA‐MB‐231 Cells by MALDI MS/MS},
  journal = {Journal of Mass Spectrometry},
  year = {2026},
  doi = {10.1002/jms.70090}
}
Start for free →